The Ovarian Cancer Diagnostics Market is being significantly influenced by regional developments and healthcare infrastructure. North America remains the market leader, driven by advanced diagnostic networks, regulatory support, and patient awareness campaigns. Europe also demonstrates steady growth, supported by government-led screening programs and investments in innovative...